# Immunosenescence-related T cell phenotypes, structural brain imaging, and cognitive impairment in patients with schizophrenia: a moderated mediation analysis

**Authors:** Na Li, Yanli Li, Ting Yu, Wenjin Chen, Mengzhuang Gou, Wenkai Zheng, Zhaofan Liu, Xiaoying Wang, Jiao Fang, Jinghui Tong, Song Chen, Baopeng Tian, Chiang-Shan R. Li, Li Tian, Yunlong Tan

PMC · DOI: 10.1038/s41537-025-00650-w · 2025-07-18

## TL;DR

This study links immune aging in T cells and brain structure changes to cognitive issues in schizophrenia patients.

## Contribution

It identifies specific T cell markers and brain regions as potential biomarkers for cognitive deficits in schizophrenia.

## Key findings

- Schizophrenia patients show immunosenescence with fewer naïve and more memory T cells compared to healthy controls.
- Higher IL-1β levels in specific T cells correlate with working memory deficits in schizophrenia patients.
- Brain structure (IPL_R thickness and CP volume) mediates and moderates the link between IL-1β and cognitive impairment.

## Abstract

Cognitive impairment is a core characteristic of schizophrenia. Immunosenescence has been consistently implicated in the cognitive dysfunction observed in neurodegenerative diseases, but how it may relate to cognitive deficits in schizophrenia is still unclear. We explored the associations between immunosenescence and cognitive impairment in patients with schizophrenia (SCZ, n = 65) and healthy controls (HCs, n = 39). Immunosenescence markers were assessed by flow cytometry and included the percentage of naïve or memory T cell subsets labeled by CD4+/CD8+, CD45RA+(naïve)/CD45RO (memory), or CD95+(memory), as well as the intracellular levels of selected cytokines (IL-1β, IL-6, TNF-α, and IFN-γ) in T cell subsets. T1-weighted magnetic resonance imaging was performed to assess the subcortical volume and cortical thickness. Participants were evaluated using the Positive and Negative Syndrome Scale and the Chinese version of the MATRICS Consensus Cognitive Battery.The results indicated that (1) Compared with HCs, SCZ patients were characterized by fewer naïve and more memory T cell subsets, accompanied by altered intracellular cytokine levels, indicating immunosenescence phenotypes. (2) The intracellular IL-1β level in naïve CD8+CD45RA+CD95+ T cells was associated with working memory deficit in SCZ patients. (3) In a moderated mediation model, the effect of the IL-1β level on the working memory score was mediated by the thickness of the right inferior parietal lobule (IPL_R), and the volume of the right choroid plexus (CP) moderated the indirect pathway between the IL-1β level and IPL_R thickness. Our findings highlighted immunosenescence-related T cell phenotypes and the CP as potential biomarkers of cognitive deficit in SCZ.

## Linked entities

- **Proteins:** IL1B (interleukin 1 beta), IL6 (interleukin 6), TNF (tumor necrosis factor), IFNG (interferon gamma)
- **Diseases:** schizophrenia (MONDO:0005090)

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** neurodegenerative diseases (MESH:D019636), SCZ (MESH:D012559), Cognitive impairment (MESH:D003072), memory deficit (MESH:D008569)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12274616/full.md

---
Source: https://tomesphere.com/paper/PMC12274616